To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
Glintborg, Bente; Loft, Anne Gitte; Omerovic, Emina; Hendricks, Oliver; Linauskas, Asta; Espesen, Jakob; Danebod, Kamilla; Jensen, Dorte Vendelbo; Nordin, Henrik; Dalgaard, Emil Barner; Chrysidis, Stavros; Kristensen, Salome; Raun, Johnny Lillelund; Lindegaard, Hanne; Manilo, Natalia; Jakobsen, Susanne Højmark; Hansen, Inger Marie Jensen; Dalsgaard Pedersen, Dorte; Sørensen, Inge Juul; Andersen, Lis Smedegaard; Grydehøj, Jolanta; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund
- 期刊名称Annals of the Rheumatic Diseases
- 作者Glintborg, Bente; Loft, Anne Gitte; Omerovic, Emina; Hendricks, Oliver; Linauskas, Asta; Espesen, Jakob; Danebod, Kamilla; Jensen, Dorte Vendelbo; Nordin, Henrik; Dalgaard, Emil Barner; Chrysidis, Stavros; Kristensen, Salome; Raun, Johnny Lillelund; Lindegaard, Hanne; Manilo, Natalia; Jakobsen, Susanne Højmark; Hansen, Inger Marie Jensen; Dalsgaard Pedersen, Dorte; Sørensen, Inge Juul; Andersen, Lis Smedegaard; Grydehøj, Jolanta; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund
- 印刷ISSN0003-4967
- 电子ISSN1468-2060
- 文件大小403.53KB
- 发表时间2018-11-05
- DOI10.1136/annrheumdis-2018-213474